Heart failure in two male patients with late‐onset Fabry mutation (IVS4 + 919G > A)
ESC Heart Failure, Volume 12, Issue 2, Page 1508-1513, April 2025.
Xufei Yang +3 more
wiley +1 more source
Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen +7 more
wiley +1 more source
Malignant Arrhythmias Caused by Pericardial Lipomas: Benign, Yet Deadly. [PDF]
Henriques M +11 more
europepmc +1 more source
LifeRhythms: The continuous commitment of the European Heart Rhythm Association in the field of arrhythmias and electrophysiology. [PDF]
Boriani G +3 more
europepmc +1 more source
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher +12 more
wiley +1 more source
Presence of Paradoxical Mid-Systolic Longitudinal Strain (Stretching) with Speckle Tracking in the Basal Inferior-to-Lateral Segments in Mitral Valve Prolapse. [PDF]
Auriti A +4 more
europepmc +1 more source
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo +10 more
wiley +1 more source
Treacherous Rhythm: Propofol Infusion Syndrome and Arrhythmogenesis. [PDF]
Summers SP, Steinberg BA.
europepmc +1 more source
Extracorporeal membrane oxygenation for refractory arrhythmia in a neonate carrying an SCN5A variant: a case report. [PDF]
Yixian C +8 more
europepmc +1 more source

